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Background Early neurological deterioration occurs
frequently after subarachnoid haemorrhage (SAH). The
impact on hospital course and outcome remains poorly
defined.
Methods We identified risk factors for worsening on
the Hunt–Hess grading scale within the first 24 h after
admission in 609 consecutively admitted aneurysmal
SAH patients. Admission risk factors and the impact of
early worsening on outcome was evaluated using
multivariable analysis adjusting for age, gender, admission
clinical grade, admission year and procedure type.
Outcome was evaluated at 12 months using the modified
Rankin Scale (mRS).
Results 211 patients worsened within the first 24 h of
admission (35%). In a multivariate adjusted model, early
worsening was associated with older age (OR 1.02, 95%
CI 1.001 to 1.03; p=0.04), the presence of intracerebral
haematoma on initial CT scan (OR 2.0, 95% CI 1.2
to 3.5; p=0.01) and higher SAH and intraventricular
haemorrhage sum scores (OR 1.05, 95% CI 1.03 to 1.08
and 1.1, 95% CI 1.01 to 1.2; p<0.001 and 0.03,
respectively). Early worsening was associated with more
hospital complications and prolonged length of hospital
stay and was an independent predictor of death (OR
12.1, 95% CI 5.7 to 26.1; p<0.001) and death or
moderate to severe disability (mRS 4–6, OR 8.4, 95% CI
4.9 to 14.5; p=0.01) at 1 year.
Conclusions Early worsening after SAH occurs in 35%
of patients, is predicted by clot burden and is associated
with mortality and poor functional outcome at 1 year.
BACKGROUND
Subarachnoid haemorrhage (SAH) is associated
with a high mortality and morbidity.1 The detri-
mental effect of medical complications in the first
2 weeks after haemorrhage on long term outcome
has been extensively studied.2–5 Additional deter-
minants of poor outcome after SAH include age,
neurological state at presentation and large aneur-
ysm size.1 After the initial neuronal damage
caused by the haemorrhage, neurological decline is
often observed. Clinical worsening may occur early
(within the first 24 h of admission) or late in the
course of the disease. Several factors have been
associated with clinical deterioration, including
aneurysm rebleeding, hydrocephalus, delayed cere-
bral ischaemia from vasospasm, and seizures.4 6–10
However, admission variables predicting early
neurological decline have not been evaluated, and
the impact of early worsening on hospital course
and outcome received little attention as a prognos-
tic variable after SAH. In this study we sought to
identify predictors for early worsening after SAH
and to determine the impact of worsening on
outcome.
METHODS
Patient population and clinical management
All SAH patients admitted to the Neurological
Intensive Care Unit of Columbia UniversityMedical
Center between July 1996 andMay2009were offered
enrolment in the Columbia University SAH
Outcomes Project (n=1227). Consent rate was 98%.
Thestudywasapprovedbythehospital’sinstitutional
review board, and in all cases written informed
consentwas obtained from thepatient or a surrogate.
The diagnosis of SAH was established by admission
CTscanorbyxanthochromiaof theCSFifCTwasnot
diagnostic. Patientswith SAHdue to trauma, arterio-
venous malformation, vasculitis or other structural
lesions(n=242),aswellasthoseaged<18 years(n=6)
oradmitted>24 hafterSAHonset (n=237)andthose
without recorded Hunt–Hess grades on admission
and worst Hunt–Hess grade within the first 24 h
(n=24) were excluded. Additionally, admission
Hunt–Hess gradeV patientswere not included in the
final analysis due to inability of further deterioration
(n=109). Clinical management according to guide-
lines set forth by theAmericanHeartAssociation has
been described in detail previously.3 4 11We record the
dayofaneurysmalSAHas ‘day0’inourdatabase.
Clinical and radiographic variables, and hospital
complications
We recorded baseline demographic data, social and
past medical history, clinical features at SAH onset
and admission CT scan, as described previ-
ously.3 4 12 13 Neurological and general medical
condition on admission was evaluated with the
Hunt–Hess scale12 and the physiological subscore
of the Acute Physiology and Chronic Health
Evaluation (APACHE)-2 scale.11 Hunt–Hess grades
on admission and at 24 h were evaluated by the
treating neurointensivist ( JC, NB, KL, SAM) and
recorded. Hospital complications were prospect-
ively recorded according to standardised defini-
tions, including fever (body temperature ≥38.3°C),
anaemia treated with blood transfusion (haemo-
globin <9.0 g/l), aneurysm rebleeding, brainstem
herniation, cerebral infarction (from any cause),
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hydrocephalus treated with CSF diversion, hyperglycaemia
(blood glucose >11 mmol/l), hyponatraemia (serum
sodium ≤130 mmol/l), hypotension (systolic blood pressure
<100 mm Hg) requiring pressors, sepsis, pneumonia, pulmon-
ary oedema, seizures and delayed cerebral ischaemia (delayed
neurological deterioration, cerebral infarction or both) due to
vasospasm.2 14 15 The Bicaudate Index was used as an esti-
mated measure for the development of hydrocephalus.
Early neurological deterioration
In every patient, admission Hunt–Hess grade and the worst
Hunt–Hess grade within the first 24 h of admission were
recorded. Early neurological deterioration was defined as any
increase in Hunt–Hess scale within the first 24 h of admission,
with grades I and II combined as a single group of good grade
patients. Procedure or sedation related deterioration was not
considered as ‘early neurological deterioration’. The second
evaluation was done ‘sedation free’ so as to minimise the effect
of sedation. If sedation was considered the culprit, then a
higher score was not assigned. External ventricular drain (EVD)
placement was immediately performed in symptomatic
patients, even before aneurysm repair. In general, EVD was in
place by the time of the second score. In patients with early
neurological deterioration, hydrocephalus requiring EVD place-
ment was performed in 27% (admission Hunt–Hess grades 1
and 2, n=24/90), 61% (admission Hunt–Hess grade 3,
n=42/69) and 81% (Hunt–Hess grade 4, n=42/52). Predictors
for early neurological deterioration included only variables
obtained on admission (demographics, past medical history,
neurological and clinical examination, laboratory analyses and
radiographic findings).
Outcome variables
Survival and functional outcomes were assessed at discharge
and at 3 and 12 months, using the modified Rankin Scale
(mRS).16 Poor outcome was defined as death or moderate to
severe disability (mRS 4–6) at 12 months. If a 12 month mRS
was not performed, day 14 (or discharge) or 3 month evalu-
ation was carried forward.
Statistical analysis
All statistical analyses were performed using SPSS 18 software
(SPSS Inc, Chicago, Illinois, USA). Significance was judged at
p<0.05. Candidate predictor variables for worsening and mor-
tality were identified by χ2 or Fisher exact tests for categorical
variables and the Mann–Whitney U or two tailed t tests for
continuous variables (table 1). Normality was assessed using
the Kolmogorov–Smirnov test. Among similar variables that
were highly intercorrelated (ie, clinical scales), only the variable
with the highest OR and smallest p value in the binary logistic
regression analysis was used as a candidate variable in the final
multivariate model. Independent predictors of early worsening,
death at 12 months and death or severe disability at 12 months
were identified with backward stepwise multiple logistic regres-
sion analysis. Factors that occurred at a frequency of <5% were
excluded from the final model. To determine the relative contri-
butions of the individual predictors, we used Bayesian informa-
tion criterion and Akaike’s information criterion of the entire
model after individual removal of each significant predictor.
Tests for interaction were performed for all variables entered
into the multivariable models. When significant two way inter-
actions were identified, we reanalysed the predictive value of
each factor after stratifying the analysis between the two levels
of the other factor.
RESULTS
Frequency of early neurological deterioration
Of the 609 patients eligible for analysis, early worsening
occurred in 35% of patients (n=211), equally distributed in
patients where aneurysm was coiled (34%) and clipped (35%).
Aneurysm repair was performed on day 1 of admission
(median, IQR 1–1). Early worsening occurred by one (58%; to
Table 1 Admission factors in relation to neurological deterioration






Age (years) 57 (16) 52 (13) 0.001
Female 154 (73) 297 (75) 0.6
Body mass index (kg/m2) 27 (6) 27 (7) 0.9
White ethnicity 99 (47) 180 (45) 0.7
Social and past medical history
Hypertension 118 (56) 175 (43) 0.004
Diabetes mellitus 17 (8) 28 (7) 0.3
Previous stroke 7 (3) 7 (2) 0.2
Admission neurological and clinical findings
Hunt–Hess grade 3 (2–3) 3 (1–3) 0.3
1 and 2, alert and oriented 90 (43) 179 (45)
3, lethargic 69 (33) 137 (34)
4, stuporous 52 (25) 82 (21)
Loss of consciousness 92 (44) 134 (34) 0.01
APACHE-2 physiological subscore* 6 (4–9) 5 (3–8) <0.001
Body temperature (°C) 98 (97–99) 98 (97–99) 0.8
Systolic blood pressure (mm Hg) 160 (138–180) 156 (133–180) 0.2
Heart rate (bpm) 82 (69–96) 80 (68–90) 0.3
Respiratory rate (/min) 18 (16–20) 18 (16–20) 0.1
Serum sodium (mmol/l) 139 (136–140) 138 (136–140) 0.9
Serum glucose (mmol/l) 146 (126–178) 137 (118–166) 0.003
White blood cell count (×109/l) 11.6 (8.8–14.5) 10.8 (8.3–13.7) 0.08
Troponin (mg/l)† 0.2 (0.02–0.5) 0.1 (0.02–0.3) 0.4
Admission radiographic findings
Modified Fisher scale 3 (2–4) 3 (1–3) <0.001
0, no blood 1 (1) 12 (3)
1, focal or diffuse thin SAH 42 (20) 124 (32)
2, focal or diffuse thin SAH
with bilateral IVH
16 (8) 29 (7)
3, focal or diffuse thick SAH 95 (45) 162 (41)
4, focal or diffuse thick SAH
with bilateral IVH
57 (27) 71 (18)
SAH sum score* 19 (14–24) 15 (10–21) <0.001
IVH sum score* 2 (0–4) 1 (0–3) 0.005
Bicaudate Index (mm) 0.17 (0.13–0.22) 0.16 (0.12–0.20) 0.004
Haematoma 42 (20) 43 (11) 0.003
Vasospasm on admission
angiogram
11 (5) 18 (5) 0.7
Aneurysm size >10 mm 54 (26) 92 (23) 0.4
Values are presented as mean (SD), median (IQR) or number (%).
*APACHE-2 physiological subscore is the sum of four physiological variables:
arterio-alveolar gradient >125 mm Hg=3, HCO3 <20 mmol/l=2, glucose
9.9 mmol/l=2 and mean arterial pressure <70 or >130 mm Hg=1 (range 0–8); SAH
sum score grades the amount of blood in 10 basal cisterns and fissures (0=no SAH,
1=small SAH, 2=moderate SAH, 3=completely filled with SAH) by adding each of
the 10 individual cistern scores (range 0–30); IVH sum score grades the amount of
blood in the right and left lateral, third and fourth ventricel (0=no blood,
1=sedimentation, 2=partly filled, 3=completely filled) by adding each of the four
individual ventricel scores (range 0–12).
†Missing variables in 45%.
APACHE, Acute Physiology and Chronic Health Evaluation, ICH, intracerebral
haemorrhage; IVH, intraventricular haemorrhage; SAH, subarachnoidal haemorrhage.
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Hunt–Hess grade 3, n=63; to Hunt–Hess grade 4, n=42; to
Hunt–Hess grade 5, n=52), two (34%; to Hunt–Hess grade 4,
n=17; to Hunt–Hess grade 5, n=27) or three (8%; to Hunt–
Hess grade 5, n=10) Hunt–Hess categories.
Predictors of early neurological deterioration
Of the clinical and radiographic variables associated with wor-
sening in the univariate analysis (table 1), older age, intracereb-
ral haematoma on initial CT scan, higher SAH sum and
intraventricular haemorrhage sum scores were independent pre-
dictors of worsening within the first 24 h (table 2), after adjust-
ing for admission Hunt–Hess grade, gender, admission year and
procedure type (surgical/endovascular treatment of ruptured
aneurysms). No interactions were found between these predic-
tors in this final model.
Hospital complications
The rate of hospital complications was higher in patients with
early neurological deterioration, as shown in table 3.
Twelve month outcome
Twelve month outcome data are presented in figure 1, including
184 patients (30%) where mRS was carried forward. Mortality
was higher in patients with early neurological deterioration
(18%, n=38, compared with 1%, n=2, at 14 days, and 28%,
n=60, compared with 3%, n=13, at 12 months, p<0.001,
respectively). Good recovery at 1 year (mRS 0–3) was observed
in 52% of patients with early neurological deterioration
(n=110) compared with 88% without neurological decline in
the first 24 h of admission (n=351, p<0.001). Of the variables
associated with mortality and severe disability and mortality in
univariate analysis, age, admission Hunt–Hess grade, inhospital
hyperglycaemia and early neurological deterioration were inde-
pendently associated with 12 month outcomes (variables that
were forced in the model were gender, admission year and sur-
gical/endovascular treatment) (table 4).
DISCUSSION
We found that early neurological deterioration after SAH is a
strong predictor of death and poor functional recovery at
1 year. Older age and overall clot burden on admission predicted
clinical worsening.
The most novel finding in this study is that the initial
haemorrhage load is an independent predictor for early
neurological deterioration after SAH, regardless of whether
the blood is intraventricular, intracerebral or in the subarach-
noid space. The association of clot burden and early neuro-
logical deterioration may be explained by the evolving mass
effect with intracerebral haemorrhage or through the devel-
opment of obstructive hydrocephalus in patients with intra-
ventricular bleeding.17 Although we did not find an
association between the Bicaudate Index on admission and
neurological deterioration, patients may have developed
hydrocephalus thereafter.
One can only speculate why the amount of subarachnoid
blood in direct contact with the brain predicts early neuro-
logical deterioration. It may be that the toxicity of blood drives
early metabolic and electrical failure of brain cells. This concept
of neurohaemoinflammation is based on mechanical, biochem-
ical and molecular changes, eventually leading to oedema, neu-
rovascular uncoupling, apopotosis and cell death.18 19 Carefully
designed studies using multimodal neuromonitoring techniques
(microdialysis, brain tissue oxygen and EEG monitoring) or
neuroimaging modalities (MR, positron emission tomography,
single photon emission computed tomography) may capture
these early pathophysiological changes in brain metabolism
and physiology.
Given the observed association between clot burden and
early worsening, another target for intervention may be found
in decreasing haemorrhage related energy demand of the
acutely injured brain after poor grade SAH by pharmacological
measures or hypothermia. Although intraoperative hypother-
mia does not improve outcome during aneurysm clipping,20 21
early and more prolonged hypothermia may be beneficial as a
means of reducing cerebral energy demand or the tissue inflam-
matory response. Another strategy to minimise the harmful
effects of subarachnoid and intraventricular blood might
include cisternal or ventricular lavage, kinetic therapy or other
methods for promoting early blood clearance.22 Early evacu-
ation of packed intraventricular haemorrhage in poor grade
SAH patients, however, did not show a favourable outcome.23
There is some evidence that lumbar drainage of CSF decreases
symptomatic vasospasm and improves outcome after SAH24
Table 2 Multivariate analysis predicting neurological deterioration
in the first 24 h*
Variable OR 95% CI p Value
Age 1.02 1.001 to 1.03 0.04
Intracerebral haematoma on initial CT 2.0 1.2 to 3.5 0.01
SAH sum score† 1.05 1.03 to 1.08 <0.001
IVH sum score† 1.1 1.01 to 1.18 0.03
*Adjusted for gender, admission Hunt–Hess grade, admission year and surgical/
endovascular treatment.
†SAH and IVH sum scores are as described in the legend to table 1.
IVH, intraventricular haemorrhage; SAH, subarachnoidal haemorrhage.
Table 3 Hospital complications and outcome in relation to





Fever >38.3°C 153 (73) 184 (46) <0.001
Anaemia treated with blood
transfusion
114 (54) 115 (29) <0.001
Aneurysm rebleeding 35 (17) 15 (4) <0.001
Herniation 52 (25) 18 (5) <0.001
Hydrocephalus treated with CSF
diversion
108 (51) 104 (26) <0.001
Hyperglycaemia (>11 mmol/l) 124 (59) 171 (43) <0.001
Hyponatraemia (<130 mmol/l) 36 (17) 59 (15) 0.477
Hypotension requiring
vasopressors
67 (32) 65 (16) <0.001
Pneumonia 82 (39) 58 (15) <0.001
Pulmonary oedema 68 (32) 44 (11) <0.001
Seizure 25 (12) 15 (4) <0.001
Sepsis 41 (19) 31 (8) <0.001
Delayed cerebral ischaemia 73 (35) 61 (15) <0.001
ICU LOS 13 (9–19) 9 (7–12) <0.001
Hospital LOS 20 (13–31) 13 (11–19) <0.001
Values are presented as median (IQR) or number (%).
χ2, Fisher exact tests or Mann-Whitney U or two tailed t tests were used as
appropriate.
ICU, intensive care unit; LOS, length of stay.
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but larger randomised trials are needed to support this
intervention.
The prognostic value of early worsening for poor outcome
at 12 months is similar to that of previously identified risk
factors, such as age, admission Hunt–Hess, rebleeding and
aneurysm size. The strong association between worsening and
various hospital complications in our study may account in
part for the association with poor outcome. Haemorrhage
load and the presence of intraventricular blood after SAH have
been associated with inhospital complications and increased
mortality.3 6 25 The most common hospital complication
among patients with early neurological deterioration was
fever (72%), which is a frequent epiphenomenon in neurocriti-
cal care patients,26 and is associated with neurological deteri-
oration and poor outcome.2 7 27 28 Prevention of fever after
SAH is a widely accepted management strategy and may
improve outcome.29
Fifty-five per cent of patients with early worsening developed
hyperglycaemia during hospitalisation. Prevention of hypergly-
caemia has previously been shown to improve outcome in sur-
gical and medical patients,30 31 but more recent trials have
challenged these findings,32 leading to controversy regarding
the optimal range of serum glucose in critical care.32 33 In
acutely brain injured patients, the detrimental effect of hyper-
glycaemia on hospital course and functional outcome has been
well studied5 34 35 but tight glycaemic control (4.4–6.2 mmol/l)
has recently been associated with brain metabolic distress,36 as
brain tissue glucose is primarily regulated by systemic supply.37
Prolonged cerebral tissue hypoglycaemia is predictive for poor
outcome,38 39 therefore arguing for a less restrictive target for
systemic glycaemic control in acutely brain injured patients.40
Several potential weaknesses of this study deserve mention.
The single centre design of our study limits the generalisability
of our results. The major limitation of this study is that other
factors, which potentially cause early neurological deterioration
(seizures, stunned myocardium, fever, etc.) were not investi-
gated as these data were not recorded in a time locked way in
our database. Furthermore, our data provide no information on
early worsening in Hunt–Hess grade V patients, as they were
not included in our analysis. Patients may deteriorate prior to
hospital admission and after the first 24 h, and our study pro-
vides no data on these events. Finally, we analysed only admis-
sion predictors of neurological worsening. Due to the complex
nature of neurological injury in SAH, we found it impossible to
reliably identify specific complications, such as intracranial
hypertension, obstructive hydrocephalus, brainstem herniation,
seizures, rebleeding or acute cerebral infarctions as the primary
cause of early worsening in individual patients. Although we
record these complications in our database, we also do not have
information regarding the timing of these events. Moreover,
the exact hour of SAH bleeding and the exact time of neuro-
logical deterioration after admission was not recorded prospect-
ively, which could also have influenced our results. If a 12
month mRS was not performed, the day 14 (or discharge) or 3
month evaluation was carried forward. The model predicting
1 year outcome was recalculated without patients with missing
12 month evaluations (30%) and did not show a significant
change in variables.
CONCLUSIONS
In conclusion, our findings indicate that early neurological
deterioration is an important predictor of poor outcome after
SAH. Carefully designed prospective studies are needed to
understand the pathophysiology of this phenomenon. Medical
therapies aimed at preventing early deterioration after SAH
may improve outcome.
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Figure 1 Outcome of patients with
(A, n=211) and without (B n=398)
early neurological deterioration using
the modified Rankin Scale (mRS) at
hospital discharge, and at 3 months
and 12 months after subarachnoidal
haemorrhage. Percentages of subjects
in different mRS categories are shown,
with grades 0–2 combined as a single
group of patients. This figure is only
reproduced in colour in the online
version.
Table 4 Predictors of mortality or severe disability and of
mortality 12 months after subarachnoidal haemorrhage*
Dead or severely
disabled† Dead
Variable OR 95% CI p Value OR 95% CI p Value
Age 1.05 1.03 to
1.07
<0.001 1.05 1.02 to
1.07
<0.001
Admission Hunt–Hess 2.6 1.9 to
3.4













0.01 12.1 5.7 to
26.1
<0.001
*Adjusted for gender, admission year and surgical/endovascular treatment.
†Defined as modified Rankin Scale >3.
‡Hyperglycaemia (≥11 mmol/l) at any point during hospitalisation.
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